Alastair MacKinnon, chief executive of Dark Blue TherapeuticsAlastair MacKinnon, chief executive of Dark Blue Therapeutics

Nasdaq’s Amgen swoops for Dark Blue Therapeutics in £622m deal

Listed US MedTech giant agrees to acquire Oxford-based firm in deal which is set to boost its early-stage oncology pipeline

ASOSASOS

Ocado & ASOS up – the tech FTSE risers & fallers in December

Mia Drennan: From holiday sales rep to £1bn+ dealmaker

businessBite
Live
Apex Rides wheels away with £420,000 funding roundOxford Quantum Circuits appoints Stojkovic as new COOBGF-backed Somerset firm acquired by CorpAcqApex Rides wheels away with £420,000 funding roundOxford Quantum Circuits appoints Stojkovic as new COOBGF-backed Somerset firm acquired by CorpAcq

Insights

View All

Subscribe to our newsletter

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.